134 related articles for article (PubMed ID: 11564018)
1. Intrarenal bacillus Calmette-Guérin therapy for carcinoma in situ of the upper urinary tract: long-term follow-up and natural course in cases of failure.
Okubo K; Ichioka K; Terada N; Matsuta Y; Yoshimura K; Arai Y
BJU Int; 2001 Sep; 88(4):343-7. PubMed ID: 11564018
[TBL] [Abstract][Full Text] [Related]
2. [Intrarenal bacillus Calmette-Guerin therapy for carcinoma in situ of the upper urinary tract].
Okubo K; Ishitoya S; Maeda H; Suzuki Y; Arai Y
Nihon Hinyokika Gakkai Zasshi; 1997 Mar; 88(3):386-90. PubMed ID: 9125861
[TBL] [Abstract][Full Text] [Related]
3. Bacillus Calmette-Guérin perfusion therapy for the treatment of transitional cell carcinoma in situ of the upper urinary tract.
Nonomura N; Ono Y; Nozawa M; Fukui T; Harada Y; Nishimura K; Takaha N; Takahara S; Okuyama A
Eur Urol; 2000 Dec; 38(6):701-4;discussion 705. PubMed ID: 11111187
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcome of bacillus Calmette-Guérin perfusion therapy for carcinoma in situ of the upper urinary tract.
Miyake H; Eto H; Hara S; Okada H; Kamidono S; Hara I
Int J Urol; 2002 Dec; 9(12):677-80. PubMed ID: 12492951
[TBL] [Abstract][Full Text] [Related]
5. [Long-term outcome of initial treatment with Bacillus Calmette-Guérin for carcinoma in situ of the upper urinary tract].
Kita Y; Soda T; Mizuno K; Matsuoka T; Nakanishi S; Asai S; Taoka R; Inoue K; Terai A
Hinyokika Kiyo; 2011 Jul; 57(7):353-7. PubMed ID: 21832868
[TBL] [Abstract][Full Text] [Related]
6. Intrarenal bacillus Calmette-Guerin therapy for upper urinary tract carcinoma in situ.
Sharpe JR; Duffy G; Chin JL
J Urol; 1993 Mar; 149(3):457-9; discussion 459-60. PubMed ID: 8437246
[TBL] [Abstract][Full Text] [Related]
7. Bacillus Calmette-Guérin instillation treatment for carcinoma in situ of the upper urinary tract.
Nishino Y; Yamamoto N; Komeda H; Takahashi Y; Deguchi T
BJU Int; 2000 May; 85(7):799-801. PubMed ID: 10792155
[TBL] [Abstract][Full Text] [Related]
8. Bacillus Calmette-Guérin failure in patients with non-muscle-invasive urothelial carcinoma of the bladder may be due to the urologist's failure to detect urothelial carcinoma of the upper urinary tract and urethra.
Giannarini G; Birkhäuser FD; Recker F; Thalmann GN; Studer UE
Eur Urol; 2014 Apr; 65(4):825-31. PubMed ID: 24144432
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcome of upper urinary tract carcinoma in situ: effectiveness of nephroureterectomy versus bacillus Calmette-Guérin therapy.
Kojima Y; Tozawa K; Kawai N; Sasaki S; Hayashi Y; Kohri K
Int J Urol; 2006 Apr; 13(4):340-4. PubMed ID: 16734847
[TBL] [Abstract][Full Text] [Related]
10. [Treatment outcome of intrarenal Bacillus Calmette-Guerin therapy for carcinoma in situ of the upper urinary tract].
Anan G; Suyama T; Takeuchi N; Nakamura K; Sakamoto S; Nihei N; Ichikawa T
Hinyokika Kiyo; 2013 May; 59(5):261-4. PubMed ID: 23719131
[TBL] [Abstract][Full Text] [Related]
11. Intrarenal bacillus Calmette-Guérin therapy for carcinoma in situ of the upper urinary tract: long-term follow-up and natural course in cases of failure.
Kawakami M
BJU Int; 2002 Apr; 89(6):640; author reply 640. PubMed ID: 11942993
[No Abstract] [Full Text] [Related]
12. Long-term outcome of intravesical bacillus Calmette-Guérin therapy with maintenance for urinary bladder carcinoma in situ: About 47 cases.
Sallami S; Khouni H; Ben Atta M; Abou El Makarim S; Zouari MB; Ben Rhouma S
Tunis Med; 2016 Dec; 94(12):844. PubMed ID: 28994883
[TBL] [Abstract][Full Text] [Related]
13. [Intrarenal Bacillus Calmette-Guerin perfusion therapy was effective for carcinoma in situ of the upper urinary tract after ileal conduit replacement : a case report].
Hayashi T; Yamanaka Y; Kinjo T; Katayama K; Kamoto A; Mori N; Yoshioka T
Hinyokika Kiyo; 2014 Apr; 60(4):175-8. PubMed ID: 24882229
[TBL] [Abstract][Full Text] [Related]
14. [Is second course intravesical Bacillus Calmette-Guerin therapy for recurrent carcinoma in situ of the bladder useful?].
Yamada Y; Hara I; Kumano M; Furukawa J; Yamanaka K; Kamidono S
Hinyokika Kiyo; 2005 Aug; 51(8):539-43. PubMed ID: 16164270
[TBL] [Abstract][Full Text] [Related]
15. Antegrade perfusion with bacillus Calmette-Guérin in patients with non-muscle-invasive urothelial carcinoma of the upper urinary tract: who may benefit?
Giannarini G; Kessler TM; Birkhäuser FD; Thalmann GN; Studer UE
Eur Urol; 2011 Nov; 60(5):955-60. PubMed ID: 21807456
[TBL] [Abstract][Full Text] [Related]
16. [Bacillus Calmette-Guerin intravesical instillation treatment for carcinoma in situ of the bladder. Gifu BCG Instillation Therapy Research Group].
Nishino Y; Yasuda M; Yokoi S; Ehara H; Yamamoto N; Takahashi Y; Ishihara S; Deguchi T; Kawada Y; Takeda A; Sakai S; Takeuchi T; Taniguchi M; Minoshima K; Hamamoto Y; Kanimoto Y; Nakano M; Fujihiro S; Nezasa S; Matsuda T; Nagatani Y; Maeda S; Tamaki M; Saito A; Komeda H
Gan To Kagaku Ryoho; 1999 Oct; 26(12):1869-73. PubMed ID: 10560414
[TBL] [Abstract][Full Text] [Related]
17. [Intracavitary bacillus Calmette-Guerin therapy for upper tract transitional cell carcinoma].
Mori H; Miyaji B; Takahashi M; Matsuda K; Tsuka H; Wada O; Aoki Y; Akino H; Muranaka K; Kanamaru H; Okada K; Imamura Y
Hinyokika Kiyo; 1996 Apr; 42(4):257-61. PubMed ID: 8693956
[TBL] [Abstract][Full Text] [Related]
18. Analysis of early failures after intravesical instillation therapy with bacille Calmette-Guérin for carcinoma in situ of the bladder.
Merz VW; Marth D; Kraft R; Ackermann DK; Zingg EJ; Studer UE
Br J Urol; 1995 Feb; 75(2):180-4. PubMed ID: 7850322
[TBL] [Abstract][Full Text] [Related]
19. Long-term followup of patients treated with 1 or 2, 6-week courses of intravesical bacillus Calmette-Guerin: analysis of possible predictors of response free of tumor.
Coplen DE; Marcus MD; Myers JA; Ratliff TL; Catalona WJ
J Urol; 1990 Sep; 144(3):652-7. PubMed ID: 2388321
[TBL] [Abstract][Full Text] [Related]
20. Long-term effects of bacille Calmette-Guérin perfusion therapy for treatment of transitional cell carcinoma in situ of upper urinary tract.
Hayashida Y; Nomata K; Noguchi M; Eguchi J; Koga S; Yamashita S; Hayashi M; Kanatake H
Urology; 2004 Jun; 63(6):1084-8. PubMed ID: 15183955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
